[May 26, 2016]

Brain Ischemia Therapeutics Pipeline Review 2016 - 8 Companies & Drug Profiles - Research and Markets

Research and Markets has announced the addition of the "Brain Ischemia - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Brain Ischemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Ischemia and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and OAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Brain Ischemia Overview
3. Therapeutics Development
4. Pipeline Products for Brain Ischemia - Overview
5. Pipeline Products for Brain Ischemia - Comparative Analysis
6. Brain Ischemia - Therapeutics under Development by Companies
7. Brain Ischemia - Therapeutics under Investigation by Universities/Institutes
8. Brain Ischemia Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Brain Ischemia - Products under Development by Companies
13. Brain Ischemia - Products under Investigation by Universities/Institutes
14. Brain Ischemia - Companies Involved in Therapeutics Development

• CohBar, Inc.
• Lixte Biotechnology Holdings, Inc.
• NeuroNascent, Inc.
• NeurOp, Inc
• Prolong Pharmaceuticals, LLC
• Spectrum (News - Alert) Pharmaceuticals, Inc.
• Sylentis S.A.U.
• Vect-Horus S.A.S.

For more information visit http://www.researchandmarkets.com/research/ntwd7d/brain_ischemia

View source version on businesswire.com: http://www.businesswire.com/news/home/20160526005815/en/

[ Back To TMCnet.com's Homepage ]